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Background: Female genital mutilation/cutting (FGM/C) is a harmful traditional practice deeply 
rooted in 28 Sub-Saharan African countries. Its prevalence in The Gambia is 76.3%. The objective 
of this study was to gain precise information on the long-term health consequences of FGM/C 
in The Gambia as well as on its impact on delivery and on the health of the newborns.
Methods: Data were collected from 588 female patients examined for antenatal care or delivery 
in hospitals and health centers of the Western Health Region, The Gambia. The information 
collected, both through a questionnaire and medical examination, included sociodemographic 
factors, the presence or not of FGM/C, the types of FGM/C practiced, the long-term health 
consequences of FGM/C, complications during delivery and for the newborn. Odds ratios, their 
95% confidence intervals, and P values were calculated.
Results: The prevalence of patients who had undergone FGM/C was 75.6% (type I: 75.6%; 
type II: 24.4%). Women with type I and II FGM/C had a significantly higher prevalence of 
long-term health problems (eg, dysmenorrhea, vulvar or vaginal pain), problems related to 
anomalous healing (eg, fibrosis, keloid, synechia), and sexual dysfunction. Women with FGM/C 
were also much more likely to suffer complications during delivery (perineal tear, obstructed 
labor, episiotomy, cesarean, stillbirth) and complications associated with anomalous healing 
after FGM/C. Similarly, newborns were found to be more likely to suffer complications such 
as fetal distress and caput of the fetal head.
Conclusion: This study shows that FGM/C is associated with a variety of long-term health 
consequences, that women with FGM/C are four times more likely to suffer complications during 
delivery, and the newborn is four times more likely to have health complications if the parturient 
has undergone FGM/C. These results highlight for the first time the magnitude of consequences 
during delivery and for the newborn, associated with FGM/C in The Gambia.
Keywords: female genital mutilation/cutting, The Gambia, sexual and reproductive health, 
Africa
Introduction
“Female genital mutilation/cutting (FGM/C) comprises all procedures that involve partial 
or total removal of the external female genitalia, or other injury to the female genital 
organs for non-medical reasons”.1 It is recognized internationally as a violation of the 
human rights of girls and women, and constitutes an extreme form of discrimination 
against women due to the health consequences, pain, and risks involved. The World Health 
Organisation estimates that 140 million women and girls in the world have been victims of 
some form of FGM/C, and each year about three million girls are at risk or are subjected 
to the practice. It is found essentially in 28 countries in Sub-Saharan Africa, as well as 
in parts of the Middle East and Asia (Yemen, Oman, United Arab Emirates, Bahrain, 
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and Northern Iraq, as well as India, Malaysia, and Indonesia), 
plus Europe, the USA and Australia, among the many other 
countries where migrants carry along their culture.2,3
In many societies, it is a rite of passage to womanhood, 
with strong ancestral and sociocultural roots. Rationalizations 
for the perpetuation of FGM/C include: preservation of ethnic 
and gender identity, femininity, female purity/virginity, and 
“family honor”; maintenance of cleanliness and health; and 
assurance of women’s marriageability.4,5 In The Gambia, 
FGM/C is carried out in girls aged between birth (7 days) up 
to preadolescence, and usually before the first menstruation 
and marriage.6–9
The World Health Organisation classified FGM/C into 
four types in 1995 and revised the classification in 2007, 
as follows:
•	 type I, partial or total removal of the clitoris and/or 
prepuce (clitoridectomy)
•	 type II, partial or total removal of the clitoris and labia 
minora, with or without excision of the labia majora 
(excision)
•	 type III, narrowing of the vaginal orifice with creation 
of a covering seal by cutting and appositioning the labia 
minora and/or the labia majora, with or without excision 
of the clitoris (infibulation)
•	 type IV, all other harmful procedures done to the female 
genitalia for nonmedical purposes, eg, pricking, piercing, 
incising, scraping, dry sex, and cauterization.
All types of FGM/C have health consequences that have 
been well documented. The immediate health complications 
include shock, hemorrhage, infection, and psychological 
sequelae,10–13 and the long-term health risks include chronic 
pain, infection, keloids, fibrosis, primary infertility, and 
psychological consequences.12–18
A higher rate of complications during delivery and 
adverse consequences for the newborn have also been 
observed in women with FGM/C in Africa and Europe.17–20 
Even FGM/C types I and II, sometimes considered as more 
innocuous, may involve severe health complications. For 
example, they have been reported to provoke unequivocal 
complications like shock, hemorrhage, urogenital infection,11 
obstetric complications,17 and sexual dysfunction.14
In The Gambia, the United Nations Children’s Fund 
multiple indicator cluster survey in 2010 showed that the 
prevalence of FGM/C remains as high as 76.3% in women 
aged 15–49 years.21 A recent study by the present authors22 
revealed that FGM/C was still practiced in all six regions in 
The Gambia and resulted in various forms of damage/injury 
in one out of three women and girls examined. All forms of 
FGM/C, even type I, lead to a high numbers of complica-
tions, especially infection associated with hemorrhage.
The objective of this study was to gather precise information 
on the health consequences of FGM/C in The Gambia by con-
ducting a survey on the long-term effects of this traditional prac-
tice as well as complications during delivery and for the newborn 
that were not considered in the first clinical survey.22 The study 
was done in the context of an initiative to integrate knowledge 
about FGM/C into the academic curriculum for health students, 
tutors, and health professionals in the country. It was included as 
part of the practicum of the last year of midwifery training at the 
School of Enrolled Community Health Nurses and Midwives in 
Mansakonko, Lower River Region, The Gambia.
Materials and methods
Study design
Previous studies have demonstrated the imprecision of self-
reported FGM/C and its health consequences.23 Thus, the 
study was designed to enable identification of the types of 
FGM/C and their associated health consequences during 
delivery by direct medical observation.
Study population
The study population included women who came to a hos-
pital or health center for antenatal care or delivery in the 
Western Health Region and were examined by a midwifery 
student, regardless of whether or not they had undergone 
FGM/C. The women answered a questionnaire and clinical 
data were collected during the examination, which took place 
between December 2010 and March 2011, in hospitals and 
health centers of the Western Health Region (Royal Victoria 
Teaching Hospital, Serekunda Hospital, FajiKunda Major 
Health Centre, Jammeh Foundation for Peace Hospital, and 
Brikama Major Health Centre), resulting in a total of 588 
women being involved.
Data collection
Data were collected by 26 Gambian midwifery students 
during their practicum at the end of specialization, when 
they had to perform physical examinations, antenatal care, 
deliveries, and post natal controls. These students were 
previously trained by the nongovernmental organization, 
Wassu Gambia Kafo, in order to be able to clearly identify 
the different types of FGM/C performed and the possible 
consequences (eg, fibrosis, keloids, synechia). They were 
also trained in data collection to develop their research skills. 
The information was recorded in a clinical form especially 
designed for the study.
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The data collection process was supervised by tutors of the 
School of Enrolled Community Health Nurses and Midwives and 
Wassu Gambia Kafo trainers, who regularly visited the students dur-
ing their four months of practicum. The patients gave their informed 
consent and the data collection was done anonymously.
Questionnaire
The questionnaire was read to the patient and if necessary trans-
lated into the local language. It gathered general data on patients 
(see patient variables) and included questions about seven 
chronic gynecological problems (see clinical variables).
Physical examination
The types and complications of FGM/C were assessed by 
direct clinical observation of the genitalia as part of the 
medical gynecological examination required for antenatal 
care and/or delivery. Data on delivery complications and the 
health of the newborn were also collected during labor and 
through physical examination of the newborn.
Variables studied
Patient variables collected included age, number of living 
children, ethnic group (Mandinka, Wolof, Fula, Djola, Sara-
hole, Serer, others), and reason for coming to the hospital or 
health center (ie, delivery, antenatal care, other).
Clinical variables related to chronic problems, collected 
through a questionnaire, included dysmenorrhea, recurrent 
urinary track infection, vulvar or vaginal pain, vaginal dis-
charge, dyspareunia (painful sexual intercourse), bleeding 
during or after intercourse, and difficult penetration during 
intercourse. Those collected through physical examination 
included presence of FGM/C (none, type I–IV) and problems 
potentially associated with FGM/C, including fibrosis, keloid 
of the clitoris and/or labia, synechia of the vulva and/or labia 
minora, and clitoral neuroma.
Clinical variables related to complications during delivery 
included perineal tearing, a prolonged active phase of labor 
(exceeding 12 hours), need for episiotomy, need for cesarean 
delivery, and fresh stillbirth. Those concerning the health of the 
newborn included presence or absence of complications, fetal 
distress (fetal heart rate , 100–160 beats per minute), caput of 
the fetal head (edematous swelling formed under the present-
ing part of the scalp in a newborn infant as a result of trauma 
sustained during delivery), fractures and other complications.
Ethical aspects
The study was approved by The Gambia Government/MRC 
Joint Ethics Committee (R08002). All women included 
in this study signed or stamped their informed consent. 
The information collected by examination was secondary 
data obtained as a result of spontaneous demand by the 
patient. The clinical register was kept in the custody of 
the midwifery students and rigorous confidentiality was 
maintained.
Statistical analysis
A descriptive analysis was carried out on the main variables, 
and their prevalences as well as 95% confidence intervals 
(95% CI) are shown. Prevalences were compared using the 
Chi-squared test. In order to highlight the effects of practic-
ing FGM/C, we did likelihood-based conformity contrasts 
for variables related to self-perception, complications during 
delivery, and health complications in the newborn in terms of 
whether or not the subject had undergone FGM/C (type I or 
II). Corresponding odds ratios and 95% CI are presented.
Results
Data were collected from a total of 588 women. Sixteen 
cases were not included in the analysis because it was not 
clear whether or not they had undergone FGM/C or which 
type of FGM/C had been performed. Out of the 572 remain-
ing cases, only two women had undergone type III FGM/C 
and consequently they were not taken into account in the 
descriptive analysis. Therefore, the final sample size was 
570 women.
The prevalence of FGM/C and the main sociodemo-
graphic variables of the 570 patients are shown in Table 1. 
A total of 24.4% (n = 139) did not have any signs of FGM/C, 
57.2% (n = 326) had undergone type I FGM/C, and 18.4% 
(n = 105) had undergone type II FGM/C. Therefore, the 
prevalence of FGM/C, defined by patients with type I or II 
FGM/C, was 75.6%.
For the three groups of women (no FGM/C, type I FGM/C, 
and type II FGM/C), a number of characteristics, including 
age, ethnic group, number of living children and reason for 
coming to the hospital or health center, were recorded. As 
shown in Table 1, the three groups of women were of similar 
mean age, ie, 25.6 years for the no FGM/C group, 26.3 years 
for the type I FGM/C group, and 25.4 years for the type 
II FGM/C group. The number of living children was also 
similar, with a mean of 1.9 for the no FGM/C group, 2.4 
for the type I FGM/C group, and 2.0 for the type II FGM/C 
group. Overall, the main reason for coming to the hospital 
or health center was delivery.With regard to ethnicity, it was 
found that FGM/C prevalence rates were 17.5% among Wolof 
and 46.2% among Serer, whereas Mandinka, Fula, Sarahole 
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Table 1 Characteristics of women with no FGM/C, type I FGM/C, and type II FGM/C
No  
FGM/C
Type I  
FGM/C
Type II  
FGM/C
Total
Age (years)
 Range 15–41 12–42 15–45 12–45
 Mean 25.6 26.3 25.4 25.9
Living children (n)
 Range 0–6 0–9 0–9 0–9
 Mean 1.9 2.4 2.0 2.2
n % n % n % n %
Casesa 139 24.4 326 57.2 105 18.4 570 100
Reason for attending  
hospital or health centerb
 Delivery 94 71.2 205 68.1 82 80.4 381 71.2
 Antenatal care 38 28.8 93 30.9 19 18.6 150 28.0
 Other 0 0 3 1.0 1 1.0 4 0.7
 Total 132 100 301 100 102 100 535 100
Ethnic groupc
 Mandinka 10 5.7 139 79.4 26 14.9 175 100
 Wolof 99 82.5 16 13.3 5 4.2 120 100
 Fula 8 6.9 80 69.0 28 24.1 116 100
 Sarahole 1 3.3 12 40.0 17 56.7 30 100
 Djola 3 3.9 54 71.1 19 25.0 76 100
 Serer 7 53.8 3 23.1 3 23.1 13 100
 Other 7 36.8 12 63.2 0 0 19 100
Notes: aOf total cases (n = 570); bof total cases in each group (no FGM/C, type I FGM/C, type II FGM/C, total); cof total cases in each ethnic group (Mandinga, Wolof, Fula, 
Saraholes, Djola, Serer, other).
Abbreviation: FGM/C, female genital mutilation/cutting.
and Djola ethnic groups practice FGM/C extensively, with 
prevalences in the range of 94.3%–96.7%.
The prevalence and 95% CI of the affirmative category 
of the clinical variables collected by questionnaire and clini-
cal examination are shown in Table 2. For all chronic health 
problems canvassed in the questionnaire (eg, dysmenorrhea, 
recurrent urinary tract infection), the percentage of posi-
tive answers was significantly higher for the type I and II 
FGM/C groups than for the group that had not undergone 
FGM/C (P , 0.001 for all Chi-squared tests). For example, 
vulvar or vaginal pain affected 5% of women who had not 
undergone FGM/C, 17.4% of women with type I FGM/C, 
and 39.8% of women with type II FGM/C. Difficult pen-
etration during intercourse was reported by 5.8%, 15.1%, 
and 50.5% of women, respectively. The 95% CI showed 
a slight overlap for dysmenorrhea, recurrent urinary tract 
infection, vaginal discharge, and bleeding during or after 
intercourse. No overlap was found for the rest of the items 
in the questionnaire.
With regard to chronic problems detected by clinical 
examination (eg, fibrosis, keloids), no cases or a very low 
number of cases (1–2) were recorded in the group that 
had not undergone FGM/C. Type I FGM/C was associ-
ated with a prevalence of fibrosis, keloids, synechia, and 
clitoral neuroma ranging from 2.5% to 15.8% whereas 
for type II FGM/C this prevalence ranged from 19.4% to 
54.4%. This finding clearly indicates that fibrosis, kelo-
ids, synechia, and clitoral neuroma are consequences of 
FGM/C, and that their prevalence rises progressively from 
type I to type II.
Table 3 shows the complications during delivery, which 
affected 11.7% of the group that had not undergone FGM/C, 
39.0% of those  with type I and 65.9% of those with type II 
FGM/C. When the different complications were analyzed, 
rates of perineal tear, need for episiotomy and prolonged 
labor were significantly increased in women who had under-
gone type I or II FGM/C. The number of stillbirths followed 
the same trend. Although the need for cesarean section was 
low in all groups, it was significantly higher for those with 
FGM/C type III.
Finally, complication rates in newborns were 5.3% for 
mothers who had not undergone FGM/C, 15.6% for mothers 
with type I and 37.8% for mothers with type II FGM/C. Fetal 
distress was observed in 3.2% of cases for mothers who had not 
undergone FGM/C, 8.8% for those with type I, and 26.8% for 
those with type II FGM/C. Caput of the fetal head was found 
among 1.1%, 14.5% and 34.2% of the groups, respectively. Data 
were also collected for other types of newborn complications, 
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Table 2 Prevalence and 95% confidence intervals of the affirmative category of the clinical variables collected by questionnaire and 
clinical examination
No FGM/C Type I FGM/C Type II FGM/C χ2 (P value)
n % 95% CI n % 95% CI n % 95% CI
Cases (n) 139   326   105   
Common symptoms
 Dysmenorrheaa 48 34.5 26.3–42.8 188 58.2 52.7–63.7 71 67.6 58.2–77.1 31.4 (,0.001)
 Recurrent urinary tract infectiona 20 14.4 8.2–20.6 63 19.6 15.0–24.0 46 44.2 34.2–54.3 34.6 (,0.001)
 Vulvar or vaginal paina 7 5.0 1.0–9.0 56 17.4 13.1–21.7 41 39.8 29.9–49.7 48.1 (,0.001)
 Vaginal dischargea 40 28.8 20.9–36.7 166 51.4 45.8–57.0 63 60.6 50.7–70.5 28.6 (,0.001)
 Painful intercoursea 18 12.9 7.0–18.9 95 29.3 24.2–34.4 60 57.1 47.2–67.1 55.6 (,0.001)
 Bleeding during or after intercoursea 3 2.2 0.5–6.2 17 5.3 2.7–7.9 33 31.4 22.1–40.8 75.3 (,0.001)
 Difficult penetration during intercoursea 8 5.8 1.5–10.0 49 15.1 12.0–19.2 53 50.5 40.4–60.5 85.3 (,0.001)
Presentation
 Fibrosisa 0 0 0–2.7 51 15.8 11.7–19.9 20 19.4 11.3–27.5 26.5 (,0.001)
 Keloid of clitorisa 0 0 0–2.7 43 13.3 9.4–17.1 37 35.6 25.9–45.3 61.3 (,0.001)
 Keloid of labiaa 1 0.8 0.02–1.1 8 2.5 0.6–4.3 22 21.6 13.1–30.0 61.7 (,0.001)
 Synechia of vulvaa 1 0.8 0.02–1.1 23 7.1 4.2–10.1 31 30.4 21.0–39.8 63.8 (,0.001)
 Synechia of labia minoraa 1 0.8 0.02–1.1 34 10.5 7.0–14.0 56 54.4 44.3–64.5 141.4 (,0.001)
 Clitoral neuromaa 2 1.5 0.18–5.3 26 8.1 4.9–11.2 21 20.6 12.3–28.9 26.9 (,0.001)
Note: aOf the total number of answers for each question and for each group (no FGM/C, type I FGM/C, type II FGM/C), that may be less than or equal to the total number 
of cases.
Abbreviations: FGM/C, female genital mutilation/cutting; CI, confidence interval.
Table 3 Prevalence and 95% confidence intervals of the affirmative category of complications during delivery and in newborn collected 
by clinical examination
No FGM/C Type I FGM/C Type II FGM/C χ2 (P value)
n % 95% CI n % 95% CI n % 95% CI
Delivery cases (n) 94 205 82
Complicationsa 11 11.7 4.7–18.7 80 39.0 32.1–45.9 54 65.9 55.0–76.7 75.4 (,0.001)
Type of complication
Perineal teara 9 9.6 3.1–16.1 57 27.8 21.4–34.2 40 48.8 37.4–60.2 51.6 (,0.001)
Prolonged labora 8 8.5 2.3–14.7 32 15.6 10.4–20.8 30 36.6 25.6–47.6 53.5 (,0.001)
Need for episiotomya 3 3.2 0.7–9.1 41 20.0 14.3–25.7 25 30.5 19.9–41.1 35.5 (,0.001)
Need for cesarean sectiona 1 1.1 0.03–5.8 1 0.5 0.01–2.7 5 6.1 2.0–13.7 12.0 (0.003)
Fresh stillbirtha 0 0 0–3.9 6 2.9 0.4–5.5 5 6.1 2.7–16.8 17.8 (,0.001)
Neonatal complications (n)a 5 5.3 1.8–12.0 32 15.6 10.4–20.8 31 37.8 26.7–48.9 44.5 (,0.001)
 Fetal distressa 3 3.2 0.7–9.1 18 8.8 4.7–12.9 22 26.8 16.6–37.0 31.6 (,0.001)
 Caput of fetal heada 1 1.1 0.03–5.8 30 14.6 9.6–19.7 28 34.2 23.3–45.0 46.8 (,0.001)
Notes: aOf total number of deliveries for each group (no FGM/C, type I FGM/C, type II FGM/C).
Abbreviations: CI, confidence interval; FGM/C, female genital mutilation/cutting.
including fracture (one case) and other type of complications 
(three cases, type unspecified); however, because the prevalence 
of these complications was not significant and their type was 
not well documented, they are not discussed here.
Table 4 presents the odds ratios (and 95% CI) for variables 
related to self-perception in women who had not undergone 
FGM/C (n = 139) and in those with type I or type II FGM/C 
(n = 431), as well as for complications during delivery and 
in neonates of parturient women who had not undergone 
FGM/C (n = 94) and in those with FGM/C (n = 287). The 
corresponding figures were not calculated for variables 
relating to gynecological examination because, as clear from 
Table 2, there were very few cases of gynecological problems 
in women who had not undergone FGM/C (range 0%–0.8%) 
whereas the figures for women with FGM/C were clearly 
different (range 7%–21%). The results show significant 
associations in all cases (P , 0.001, except for recurrent 
urinary tract infection), particularly for vulvar or vaginal pain 
(odds ratio 5.58; 95% CI 2.52–12.33) and painful intercourse 
(odds ratio 3.80; 95% CI 2.23–6.48).
Finally, we performed likelihood-based conformity con-
trasts, with statistical significance levels of P , 0.0001 in all 
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cases. This confirms the strength of the associations observed 
using odds ratios and their 95% CI.
Discussion
Clinical examination showed a prevalence of 75.6% for type I 
and type II FGM/C. This finding is consistent with that of the 
United Nations Children’s Fund multiple indicator cluster 
survey in 2010 where the prevalence of FGM/C in women 
aged 15–49 years was found to be 76.3%.21 Moreover, in that 
study, out of 431 women with FGM/C, 75.6% (n = 326) were 
found to have type I FGM/C and 24.4% had type II FGM/C. 
These percentages are comparable with the results of a pre-
vious study by the same authors,22 where type I and type II 
FGM/C accounted for 66.2% and 26.3% of cases, respectively, 
in a nationwide study. Therefore, it can be concluded that the 
group of women analyzed is fully representative of the adult 
female population in The Gambia with regard to prevalence 
and types of FGM/C practiced. Our findings do differ signifi-
cantly from those reported by a study conducted in 2001 by 
Morison et al15 in which 98% of women with FGM/C had type 
II. However, that study was performed in the specific area of 
Farafenni (Northbank East), where there is a predominance 
of one ethnic group, the Mandinka, so direct comparison with 
the present work, which covers the Western Health Region 
and all major ethnic groups, is not feasible.
Comparison of sociodemographic factors (age, number 
of living children, reason for coming to the hospital or health 
center) showed that the three groups (no FGM/C, type I 
FGM/C, type II FGM/C) were homogeneous, suggesting 
that these factors cannot be responsible for the differences 
observed regarding clinical variables. However, the three 
goups of women differed in terms of ethnic group distribu-
tion, with the Mandinka, Fula, Sarahole and Djola practicing 
FGM/C extensively, whereas the remaining ethnic groups, 
particulalry the Wolof, do not. This reflects the fact that 
FGM/C has deep sociocultural roots and that its practice is 
strongly associated with belonging to a given ethnic group, 
as mentioned previously by several investigators.6–9,15
The results of the questionnaire and medical examinations 
indicate that type I and II FGM/C are responsible for the 
increased prevalence of various long-term health problems. 
Higher rates of dysmenorrhea have been documented previ-
ously in women with type I and II FGM/C, and attributed to 
chronic pelvic infection, pelvic congestion due to the small 
vaginal opening, and genital infection, all being late sequelae 
of FGM/C.24–26 The higher rates of recurrent urinary tract 
infection and vaginal discharge in women with FGM/C are 
linked with genital infections and chronic pelvic inflammatory 
disease, as previously stated.25,26 The higher rates observed 
for vulvar or vaginal pain in women with FGM/C have also 
been documented previously and attributed to trapped or 
unprotected nerve endings as a result of cutting.24
Clinical examination conf irmed that FGM/C can 
lead to anomalous healing,22,24,27 generating a variety of 
Table 4 Prevalence and OR (95% CI) of the affirmative category of the clinical variables and of the delivery and newborn complications, 
for the no FGM/C and FGM/C (type I and II) groups
Maternal symptoms n (%) OR (95% CI) P value
No FGM/C Type I and II FGM/C
Dysmenorrheaa 64 (34.5) 260 (60.5) 2.91 (1.95–4.33) ,0.001
Recurrent urinary tract infectiona 20 (14.4) 109 (25.5) 2.05 (1.21–3.45) 0.07
Vulvar or vaginal paina 7 (5.0) 99 (22.8) 5.58 (2.52–12.33) ,0.001
Vaginal dischargea 40 (28.8) 230 (53.6) 2.86 (1.89–4.33) ,0.001
Painful intercoursea 18 (12.9) 156 (36.1) 3.80 (2.23–6.48) ,0.001
Bleeding during or after intercoursea 3 (2.2) 51 (11.7) 5.99 (1.84–19.54) ,0.001
Difficult penetration during intercoursea 8 (5.8) 103 (24.0) 5.12 (2.42–10.79) ,0.001
Complications during deliveryb 11 (11.7) 134 (46.9) 6.70 (3.42–13.1) ,0.001
 Perineal tearb 9 (9.6) 97 (33.8) 4.82 (2.33–10.00) ,0.001
 Prolonged laborb 8 (8.6) 62 (21.6) 2.96 (1.36–6.44) 0.003
 Need for episiotomyb 3 (3.2) 66 (24.7) 9.06 (2.78–29.56) ,0.001
 Need for cesareanb 1 (1.1) 6 (2.3) – –
 Fresh stillbirthb 0 (0.0) 11 (3.8) – –
Neonatal complicationsb 5 (5.3) 63 (22.5) 5.17 (2.01–13.28) ,0.001
 Fetal distressb 3 (3.2) 40 (13.9) 4.91 (1.48–13.27) 0.005
 Caput of fetal headb 1 (1.1) 58 (20.6) – –
Notes: aOf total number of answers for each question and for each group (no FGM/C, type I and II FGM/C), that may be less than or equal to the total number of cases; bof 
the total number of deliveries for each group (no FGM/C, type I and II FGM/C); (-) not calculated because of insufficient number of cases.
Abbreviations: CI, confidence interval; FGM/C, female genital mutilation/cutting; OR, odds ratio.
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consequences, including fibrosis, keloid of the clitoris (type 
I and II FGM/C), and keloid of the labia (type II FGM/C). 
Consistent with the definition of FGM/C types, keloid of 
the labia was rarely observed for women with type I FGM/C 
(2.5%) and commonly observed for women with type II 
FGM/C (21.6%).
Problems during healing can cause adhesion (synechia) 
of the two portions of the labia minora, and were observed 
in women with type I or II FGM/C. Although it is clear that 
cutting of the labia minora and/or majora can potentially 
lead to synechia in women with type II FGM/C, it is unclear 
how type I FGM/C can cause synechia of the labia or vulva 
(seen, respectively, in 7.1% and 10.5% of cases). To explain 
these results, it is probably necessary to take into account 
the fact that FGM/C is often practiced by an old woman 
using an instrument that does not facilitate high precision 
in cutting (eg, a knife), without anesthesia, and therefore 
the anatomical extent of the cutting can easily exceed the 
region of the clitoris for type I FGM/C. The two cases of 
synechia of the vulva and labia minora in women without 
FGM/C were probably of the naturally occurring variety, as 
reported in the literature.28
Clitoral neuroma was observed in 8.1% of women with 
type I FGM/C and in 20.6% of women with type II FGM/C, 
indicating that clitoral neuroma may be a more frequent 
complication in women with FGM/C than previously 
thought.29,30
The present results also show that type I and II FGM/C 
have a negative impact on women’s sexual lives when 
compared with women who have not undergone FGM/C, 
as previously reported.14,25,31 Rates of painful intercourse 
(dyspareunia), bleeding during or after intercourse, and dif-
ficult penetration were increased by a factor of 4–9 compared 
with women who had not undergone FGM/C. The presence 
of these sexual problems is consistent with the higher rates 
of vulvar or vaginal pain, clitoral neuroma, and healing 
pathologies seen in these women.
The results shown in Table 2 demonstrate that FGM/C 
has permanent health consequences for women and that it 
negatively affects their sexual life in comparison with women 
who do not undergo FGM/C. Our results confirm those of 
our previous study,22 in which significantly higher rates of 
late complications related to FGM/C were found, especially 
abnormal scarring and infection. However, again, our present 
results differ from those reported by Morison et al,15 where it 
was found that women with FGM/C have a higher prevalence 
of bacterial vaginosis and herpes simplex virus 2, and no 
other late associated complications.
FGM/C also has negative repercussions for delivery and 
the health of the newborn. Complication rates increased 
dramatically in women with type I or II FGM/C (39.0% 
and 65.9%, respectively) compared with women who had 
not undergone FGM/C (11.7%). The obstetric complication 
most often found in all three groups was perineal tearing, but 
with a prevalence three times higher for women with type I 
FGM/C (27.8%) and five times higher for women with type II 
FGM/C (48.8%) compared with women who had not under-
gone FGM/C (9.6%). The higher frequency of perineal tear 
among women with FGM/C, which has also been observed by 
other researchers,19,25,32 is attributed to loss of elasticity of the 
perineal tissue because of scar tissue and abnormal scarring 
(fibrosis and keloids). This loss of elasticity of the perineum 
is also thought to be related to the much greater prevalence 
of episiotomy observed for women with type I (20.0%) and 
type II (30.5%) FGM/C, in comparison with women who had 
not undergone FGM/C (3.2%). Prolonged labor was also more 
frequent among women with FGM/C.
The practice of cesarean section was low in all cases, 
which can be related to the poor sanitary conditions found 
in The Gambia, where only 2.2% of births in the four main 
hospitals are delivered by cesarean section, with 79% of 
these procedures being performed at the Royal Victoria 
Teaching Hospital.33 However, rates of cesarean section were 
significantly higher for women with type II FGM/C (6.1%). 
Although FGM/C does not directly affect the main factors 
responsible for cesarean section (inability of the head of the 
baby to pass throughout the pelvis), it can be hypothesized 
that cesarean section was done preventively in women with 
severe abnormal scarring and/or synechia, which is more 
frequently observed in women with type II FGM/C.
Finally, higher rates of fresh stillbirth were observed for 
women with type I or II FGM/C, as previously observed by 
other researchers.18,19,34 These stillbirths are linked to a pro-
longed second stage of labor, because of obstruction and loss 
of tissue elasticity. Macerated stillbirth was not considered 
because it cannot be related to FGM/C.
Complications during delivery also have serious repercus-
sions for the health of the newborn. Fetal distress was more 
commonly observed in the babies of women with type I or II 
FGM/C, confirming the fact that prolonged labor as a result 
of FGM/C affects the health of the newborn, as reflected in 
the stillbirth rates. In addition, the frequency of caput of the 
fetal head increased from 1.1% (n = 1) during deliveries for 
women without FGM/C to 14.6% and 34.2% for women with 
FGM/C types I and II respectively, again as a consequence 
of prolonged labor.
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These results highlight the strong relationship between 
FGM/C and a higher rate of maternal and fetal complications. 
This finding needs to be discussed in relation to the poor 
sanitary conditions of The Gambia.35,36 Cham et al35 have 
demonstrated that the availability and quality of emergency 
obstetric care is deficient, and that there is an endemic lack 
of blood for transfusion and shortage of essential medicine, 
even in the Royal Victoria Teaching Hospital in Banjul, 
which is the main referral hospital in the country. The 
maternal-fetal complications reported here are probably 
not managed with all the necessary materials and resources, 
possibly resulting in a worsening of health for both mother 
and baby in the days following delivery.
In addition, the present study only involved pregnant 
women who delivered in a health facility, whereas it has been 
reported that 70% of deliveries in The Gambia occur at home, 
supervised by a traditional birth attendant or a relative.35 This 
is especially relevant in the rural Central and Upper River 
regions, where the prevalence of FGM/C has been docu-
mented to be higher21 and where emergency obstetric care is 
seriously deficient, resulting in high maternal mortality.37 For 
this rural population, it can be hypothesized that the obstetric 
consequences related to FGM/C are even worse.
There is no doubt that the maternal-fetal complications 
directly attributable to the practice of FGM/C significantly 
worsen the health of women and their babies in a country 
where maternal mortality is ranked among the highest in 
Africa, estimated at 1050 per 100,000 live births,37 and where 
the infant mortality rate is 57 per 1000 live births.38
Conclusion
This survey, the first on FGM/C obstetric outcomes in 
The Gambia, highlights the fact that complications during 
delivery are markedly increased for women with FGM/C in 
comparison with women who have not undergone FGM/C, 
as are the rates of stillbirth and health complications for 
newborns. This study is unique in the sense that the data 
were collected by Gambian midwifery students during their 
practicum at the end of specialization, thus contributing to 
building the capacities of both the students and their tutors 
on FGM/C and social research skills. Our results, apart 
from their intrinsic scientific value, are also very useful for 
transferring medical knowledge regarding the harmfulness of 
FGM/C to Gambian health professionals, and reinforce the 
need for implementation of a national training programme 
for health professionals and students regarding the issue of 
FGM/C, that highlights the health consequences observed 
in The Gambia.
These clinical results also have a high social value, as 
proved in 2011 when they were presented at the Colloquium 
of West African Imams and Oulemas, in Mauritania, leading 
to a Fatwa (resolution) recognizing FGM/C as a harmful 
practice and conf irming the commitment of Muslim 
authorities to avoid its perpetuation.
Acknowledgments
This study was made possible by the close collaboration 
between tutors and students from the School of Enrolled 
Community Health Nurses and Midwives in Mansakonko, 
The Gambia, and Wassu Gambia Kafo, especially Mr. Barra 
Njie. They are all gratefully acknowledged. We are also very 
thankful to the Fundació “La Caixa”, Diputación Foral de 
Álava and Agencia Española de Cooperación Internacional 
para el Desarrollo (AECID) for funding the project.
Disclosure
The authors report no conflicts of interest in this work.
References
1. World Health Organization. Eliminating female genital mutilation: 
an interagency statement. OHCHR, UNAIDS, UNDP, UNECA, 
UNESCO, UNFPA, UNHCR, UNICEF, UNIFEM, WHO. Geneva, 
Switzerland; 2008. Available from: http://whqlibdoc.who.int/publica-
tions/2008/9789241596442_eng.pdf. Accessed March 18, 2013.
2. Kaplan-Marcusán A, Torán-Montserrat P, Moreno-Navarro J, 
Castany-Fàbregas MJ, Muñoz -Ortiz L. Perception of primary health 
professionals about female genital mutilation: from healthcare to 
 intercultural competence. BMC Health Serv Res. 2009;9:11.
3. Kaplan-Marcusán A, Fernández del Rio N, Moreno-Navarro J, et al. 
Female genital mutilation: perceptions of healthcare professionals and the 
perspective of the migrant families. BMC Public Health. 2010;10:193.
4. Gage AJ, Van Rossem R. Attitudes toward the discontinuation of female 
genital cutting among men and women in Guinea. Int J Gynecol Obstet. 
2006;92:92–96.
5. United Nations Children’s Fund. The dynamics of social change towards 
the abandonment of female genital mutilation/cutting in five African 
countries. Florence, Italy: Innocenti Digest, UNICEF Innocenti Research 
Centre; 2010. Available from: http://www.unicef-irc.org/publications/
pdf/fgm_insight_eng.pdf. Accessed March 19, 2013.
6. Ahmadu F. Rite and wrongs: an insider/outsider reflects on power 
and excision. In: Shell-Duncan B, Hernlund Y, editors. Female 
“Circumcision” in Africa: Culture, Controversy and Change. London, 
UK: Rienner Publishers; 2000.
7. Hernlund Y. Cutting without ritual and ritual without cutting: female 
circumcision and the re-ritualization of initiation in The Gambia. In: 
Shell-Duncan B, Hernlund Y, editors. Female “Circumcision” in Africa: 
Culture, Controversy and Change. London, UK: Rienner Publishers; 
2000.
8. Kaplan A. From Senegambia to Catalonia: acculturation and social 
integration process. X Award Dr Rogeli Duocastella in Social Sciences, 
Fundación La Caixa, Barcelona; 1998, Spanish.
9. Kaplan A. Learning about motherhood and reproductive health as a global 
adult education strategy: the case of rural African migrant women in 
Europe. [Stratégies éducatives, familles et dynamiques démographiques]. 
Paris, France: CICRED; 1999. French. Available from: http://www.
reproductive-health-journal.com/content/8/1/26. Accessed March 17, 
2013.
submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
330
Kaplan et al
International Journal of Women’s Health
Publish your work in this journal
Submit your manuscript here: http://www.dovepress.com/international-journal-of-womens-health-journal
The International Journal of Women’s Health is an international, peer-
reviewed open-access journal publishing original research, reports, 
editorials, reviews and commentaries on all aspects of women’s 
healthcare including gynecology, obstetrics, and breast cancer. The 
manuscript management system is completely online and includes 
a very quick and fair peer-review system, which is all easy to use. 
Visit http://www.dovepress.com/testimonials.php to read real quotes 
from published authors.
International Journal of Women’s Health 2013:5
 10. Dare FO, Oboro VO, Fadiora SO, Orji EO, Sule-Odu AO, Olabode TO. 
Female genital mutilation: an analysis of 522 cases in South-Western 
Nigeria. Int J Gynecol Obstet. 2004;24:281–283.
 11. Almroth L, Bedri H, El Musharaf S, et al. Urogenital complications 
among girls with genital mutilation: a hospital-based study in Khartoum. 
Afr J Reprod Health. 2005;9:118–124.
 12. Behrendt A, Moritz S. Posttraumatic stress disorder and memory 
problems after female genital mutilation. Am J Psychiatry. 2005;162: 
1000–1002.
 13. Kilizhan JI. Impact of psychological disorders after female genital 
mutilation among Kurdish girls in Northern Iraq. Eur J Psychiatry. 
2011;25:92–100.
 14. Alsibiani SA, Rouzi AA. Sexual function in women with female genital 
mutilation. Fertil Steril. 2010;93:722–724.
 15. Morison L, Scherf C, Ekpo G, et al. The long-term reproductive health 
consequences of female genital cutting in rural Gambia: a community-
based survey. Trop Med Int Health. 2001;6:643–653.
 16. Elmusharaf S, Elkhidir I, Hoffmann S, Almroth L. A case-control study 
on the association between female genital mutilation and sexually 
transmitted infections in Sudan. BJOG. 2006;113:469–474.
 17. Banks E, Meirik O, Farley T, Akande O, Bathija H, Ali M; WHO Study 
Group on Female Genital Mutilation and Obstetric Outcome. Female 
genital mutilation and obstetric outcome: WHO collaborative prospec-
tive study in six African countries. Lancet. 2006;367:1835–1841.
 18. Chibber R, El-Saleh E, El Harmi J. Female circumcision: obstetrical 
and psychological sequelae continues unabated in the 21st century. 
J Matern Fetal Neonatal Med. 2011;24:833–836.
 19. Larsen E, Okonofua FE. Female circumcision and obstetric 
complications. Int J Gynaecol Obstet. 2002;77:255–265.
 20. Wuest S, Raio L, Wyssmueller D, et al. Effects of female genital  mutilation 
on birth outcomes in Switzerland. BJOG. 2009;116:1204–1209.
 21. Gambia Bureau of Statistics. The Gambia Multiple Indicator Cluster 
Survey 2010 Report. Banjul, The Gambia; 2011. Available from: http://
www.childinfo.org/files/MICS4_Gambia_2010_FinalReport_Eng.pdf. 
Accessed March 18, 2013.
 22. Kaplan A, Hechavarría, Martín M, Bonhoure I. Health consequences of 
female genital mutilation/cutting in the Gambia, evidence into action. 
Reprod Health. 2011;8:26.
 23. Elmusharaf S, Elhadi N, Almroth L. Reliability of self reported form 
of female genital mutilation and WHO classification: cross sectional 
study. BMJ. 2006;333:124–127.
 24. Okonofua FE, Larsen U, Oronsaye F, Snow RC, Slanger TE. The 
association between female genital cutting and correlates of sexual 
and gynaecological morbidity in Edo State, Nigeria. BJOG. 2002;109: 
1089–1096.
 25. Elnashar A, Abdelhady R. The impact of female genital cutting on health 
of newly married women. Int Gynaecol Obstet. 2007;97:238–244.
 26. Karimi P, Yari S, Loghami N. Female genital mutilation: medical 
complications of a human right violation. Poster presented at the 13th 
International Congress on Infectious Diseases, Kuala Lumpur, Malaysia, 
June 19–22, 2008.
 27. Jones H, Diop N, Askew I, Kabore I. Female genital cutting practices 
in Burkina Faso and Mali and their negative health outcomes. Stud Fam 
Plann. 1999;30:219–230.
 28. Christensen EH, Oster J. Adhesions of labia minora (synechia vulvae) 
in childhood. A review and report of fourteen cases. Acta Paediatr. 
1971;60:709–715.
 29. Fernández-Aguilar S, Noël J-C. Neuroma of the clitoris after female 
genital cutting. Obstet Gynecol. 2003;101:1053–1054.
 30. Abdulcadir J, Pusztaszeri M, Vilarino R, Dubuisson JB, Vlastos AT. 
Clitoral neuroma after female genital mutilation/cutting: a rare but 
possible event. J Sex Med. 2012;9:1220–1225.
 31. Odoi A, Brodyb SP, Elkins TE. Female genital mutilation in rural Ghana, 
West Africa. Int J Gynecol Obstet. 1997;56:179–180.
 32. Ndiaye P, Diongue M, Faye A, Ouedraogo D, Tal Dia A. Mutilation 
génitale féminine et complications de l’accouchement dans la prov-
ince de Gourma (Burkina Faso) [Female genital mutilation and 
childbirth complications in the province of Gourma]. Santé Publique. 
2010;22:563–570. French.
 33. Fauveau V. Program note: Using UN process indicators to assess needs in 
emergency obstetric services: Gabon, Guinea-Bissau, and The Gambia. 
Int J Gynecol Obstet. 2007;96:233–240.
 34. Oduro AR, Ansah P, Hodgson A, et al. Trends in the prevalence of female 
genital mutilation and its effects on delivery outcomes in the Kassena-
Nankana district of Northern Ghana. Ghana Med J. 2006;40:87–92.
 35. Cham M, Sundby J, Vangen S. Availability and quality of emergency 
obstetric care in Gambia’s main referral hospital: women-users’ 
 testimonies. Reprod Health. 2009;6:5.
 36. Cole-Ceesay R, Cherian M, Sonko A, et al. Strengthening the emergency 
healthcare system for mothers and children in The Gambia. Reprod 
Health. 2010;7:21.
 37. Cham M, Sundby J, Vangen S. Maternal mortality in the rural Gambia, 
a qualitative study on access to emergency obstetric care. Reprod Health. 
2005;2:3.
 38. Millennium Development Goals Indicators. Available from: http://mdgs.
un.org/unsd/mdg/. Accessed May 17, 2012.
submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
Dovepress
331
Female genital mutilation/cutting in The Gambia
